FDA/CDC

FDA approves premixed, low-volume colon-cleansing solution


 

The Food and Drug Administration has approved a premixed sodium picosulfate, magnesium oxide, and anhydrous citric acid oral solution (Clenpiq) for cleansing of the colon in adults preparing to undergo colonoscopy, according to Ferring Pharmaceuticals.

The sodium picosulfate, magnesium oxide, and anhydrous citric acid oral solution is a relatively low-volume, premixed, cranberry-flavored solution, making it easier to use and more palatable for patients.

The oral solution is approved with two dosing options: split dose, one dose the evening prior and one dose the morning of the procedure, or the day before dose, which involves taking both doses the day prior to the procedure. Day before dosing is an alternative and should be used when split dosing is not appropriate. After each dose of sodium picosulfate, magnesium oxide, and anhydrous citric acid oral solution, clear liquids should be consumed based on the dosing recommendation. The American College of Gastroenterology recommends the split-dose regimen because of its improved cleansing quality of the colon and better tolerability of the liquid volume by patients.

Patients with impaired renal function should exercise caution if using sodium picosulfate, magnesium oxide, and anhydrous citric acid oral solution as it may effect renal function. A more comprehensive list of safety information is available at www.clenpiq.com.

Recommended Reading

AGA Clinical Practice Update: Treatment of fecal incontinence and defecatory disorders
MDedge Family Medicine
The Liver Meeting 2017 NAFLD debrief – key abstracts
MDedge Family Medicine
Does incretin therapy increase pancreatic cancer risk?
MDedge Family Medicine
Adjusting fecal immunochemical test thresholds improved their performance
MDedge Family Medicine
VIDEO: Study supports close follow-up of patients with high-risk adenomas plus serrated polyps
MDedge Family Medicine
Antibiotic overprescribing: Still a major concern
MDedge Family Medicine
Biologics during pregnancy did not affect infant vaccine response
MDedge Family Medicine
Fecal microbiota transplants by oral capsule noninferior to colonoscopy
MDedge Family Medicine
How to address these 3 opioid adverse effects
MDedge Family Medicine
FDA recommends voluntary recall of Limbrel
MDedge Family Medicine